Sign in

Research summary ·

Thyroid dysfunction risk in systemic lupus erythematosus: a systematic review of case-control studies.

Written based on 1 research study on PubMed, searched on 5 Nov 2026.

What was studied

This study looked at thyroid problems in people with lupus, or SLE. It covered high and low thyroid function and euthyroid sick syndrome, or ESS. First it checked prevalence in cohorts from Luzhou and Enshi. A meta-analysis then pooled studies from PubMed and other databases. The team also studied factors linked to thyroid problems. Patients were compared with healthy controls.

What they found

All thyroid problem types were more common in SLE patients than in healthy controls. The meta-analysis agreed at a global level for clinical hypothyroidism, subclinical hyperthyroidism and ESS. Clinical hypothyroidism linked to renal involvement, P = 0.017. It also linked to low FT3 levels, P < 0.001. ESS linked to low C3, P < 0.001. It also linked to low FT3 levels, P = 0.007.

What it means for patients

The authors say thyroid dysfunction is prevalent in SLE patients worldwide. They say severe renal involvement and low FT3 levels mark higher risk of clinical hypothyroidism. They say low FT3 and C3 levels link to a higher risk of ESS.

Why it is not certain yet

The studies were case-control designs. The links are associations, not proof of cause. The abstract gives no prevalence numbers. It does not say how many patients were in the cohorts. The cohorts came from Luzhou and Enshi only.

Source

Thyroid dysfunction risk in systemic lupus erythematosus: a systematic review of case-control studies.

PubMed · PMID 42718833

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Lupus (SLE) publications